Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1055
Europe Platelet Rich Plasma Market is poised to register a CAGR of over 7.1% during the forecast period 2022 to 2028. Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Europe platelet rich plasma market includes market size for platelet-rich plasma systems and platelet-rich plasma kits. The market report includes Europe platelet-rich plasma market value analysis by product type, applications, end user and country. PRP Systems Platelet-rich plasma systems included in this report are centrifuge systems specifically for separation of platelet-rich plasma and platelet poor plasma from autologous blood samples drawn at the point-of-care facility. Other centrifuge systems which have application in other cellular therapies and preparation of substances derived from body fluids are excluded from the scope of this report Examples of PRP systems included in this report are GPS® III Platelet Concentration System (Zimmer Biomet), The Arthrex ACP® Double Syringe System (Arthrex Inc), Arthrex Angel® cPRP Processing System (Arthrex Inc.) etc. among others PRP Kits PRP kits considered in this segment of the report include PRP preparation kits and PRP harvest kits. PRP Kit that makes Platelet-Rich Plasma extractions simple and cost-efficient PRP preparation and harvest kits generally include PRP Tubes, Re-Suspension Tube, injectors, needles, phlebotomy sets etc. PRP kits are made available to end users through three prominent sales channels. Sales channels included in this report are Direct Sales Channels, Distributor Sale Channels, and Others (group purchasing organisations, wholesalers, pharmacists etc.) Market Dynamics: Sales Channel Being low margin product, direct sales channel sub-segment of PRP kits product type is the most popular End User All clinics segments collectively experience high demand for PRP kits in Europe Applications High demand for PRP kits is from cosmetic applications, including Skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc. In U.K., PRP treatment industry is well established. However, there's limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have partnership with manufacturing companies Key market players are Terumo BCT, Zimmer Biomet, NeoGenesis Co. Ltd, Glofinn oy Overview, T Biotechnology (T Lab), Regen Lab SA, SDD Medical Group Ltd Overview, IntraVita International Limited Overview, Exactech Inc., Arthrex Inc., Biotechnology Institute (bti). Europe Platelet Rich Plasma Market Segmentation By Product Type • Instruments • Kits o Kit By Type • Pure Platelet-Rich Plasma (P-PRP) • Leukocyte-Rich Platelet-Rich Plasma (L-PRP) • Leukocyte-Platelet-Rich Fibrin (L-PRF) • Pure Platelet-Rich Fibrin (P-PRF) o Kit By Origin • Autologous Platelet-Rich Plasma • Homologus Platelet-Rich Plasma • Allogeneic Platelet-Rich Plasm By Application Cosmetic/Aesthetic/Hair Fall Treatment Orthopedics/Rehabilitation medicine Dentistry Ophthalmology Research and Development Veterinary By End Users Physician's office/Private Practice/Veterinary Clinics Hospitals Orthopedic Clinics Cosmetic/dermatology/Trichology Clinics Academic & Research Institutes By Region North America Europe Asia-Pacific Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key datapoints affecting market growth Objectives of the Study: To provide with an exhaustive analysis on Europe platelet rich plasma market by product, application, end-user and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and overall market To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America, Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Europe platelet rich plasma market includes market size for platelet-rich plasma systems and platelet-rich plasma kits.
The market report includes Europe platelet-rich plasma market value analysis by product type, applications, end user and country.
PRP Systems
Platelet-rich plasma systems included in this report are centrifuge systems specifically for separation of platelet-rich plasma and platelet poor plasma from autologous blood samples drawn at the point-of-care facility.
Other centrifuge systems which have application in other cellular therapies and preparation of substances derived from body fluids are excluded from the scope of this report
Examples of PRP systems included in this report are GPS® III Platelet Concentration System (Zimmer Biomet), The Arthrex ACP® Double Syringe System (Arthrex Inc), Arthrex Angel® cPRP Processing System (Arthrex Inc.) etc. among others
PRP Kits
PRP kits considered in this segment of the report include PRP preparation kits and PRP harvest kits. PRP Kit that makes Platelet-Rich Plasma extractions simple and cost-efficient
PRP preparation and harvest kits generally include PRP Tubes, Re-Suspension Tube, injectors, needles, phlebotomy sets etc.
PRP kits are made available to end users through three prominent sales channels. Sales channels included in this report are Direct Sales Channels, Distributor Sale Channels, and Others (group purchasing organisations, wholesalers, pharmacists etc.)
Market Dynamics:
Being low margin product, direct sales channel sub-segment of PRP kits product type is the most popular
All clinics segments collectively experience high demand for PRP kits in Europe
High demand for PRP kits is from cosmetic applications, including Skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc.
In U.K., PRP treatment industry is well established. However, there's limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have partnership with manufacturing companies
Key market players are Terumo BCT, Zimmer Biomet, NeoGenesis Co. Ltd, Glofinn oy Overview, T Biotechnology (T Lab), Regen Lab SA, SDD Medical Group Ltd Overview, IntraVita International Limited Overview, Exactech Inc., Arthrex Inc., Biotechnology Institute (bti).
Europe Platelet Rich Plasma Market Segmentation
By Product Type • Instruments • Kits o Kit By Type • Pure Platelet-Rich Plasma (P-PRP) • Leukocyte-Rich Platelet-Rich Plasma (L-PRP) • Leukocyte-Platelet-Rich Fibrin (L-PRF) • Pure Platelet-Rich Fibrin (P-PRF) o Kit By Origin • Autologous Platelet-Rich Plasma • Homologus Platelet-Rich Plasma • Allogeneic Platelet-Rich Plasm
By Application
By End Users
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Europe Platelet Rich Plasma Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Europe Platelet Rich Plasma Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Europe Platelet Rich Plasma Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Europe Platelet Rich Plasma Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.2. Kits 7.2.1. Kit By Type 7.2.1.1. Pure Platelet-Rich Plasma (P-PRP) 7.2.1.2. Leukocyte-Rich Platelet-Rich Plasma (L-PRP) 7.2.1.3. Leukocyte-Platelet-Rich Fibrin (L-PRF) 7.2.1.4. Pure Platelet-Rich Fibrin (P-PRF) 7.2.2. Kit By Origin 7.2.2.1. Autologous Platelet-Rich Plasma 7.2.2.2. Homologus Platelet-Rich Plasma 7.2.2.3. Allogeneic Platelet-Rich Plasma 8. Europe Platelet Rich Plasma Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cosmetic/Aesthetic/Hair Fall Treatment 8.2. Orthopedics/Rehabilitation medicine 8.3. Dentistry 8.4. Ophthalmology 8.5. Research and Development 8.6. Veterinary 9. Europe Platelet Rich Plasma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Physician's office/Private Practice/Veterinary Clinics 9.2. Hospitals 9.3. Orthopedic Clinics 9.4. Cosmetic/dermatology/Trichology Clinics 9.5. Academic & Research Institutes 10. North America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Terumo BCT 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Zimmer Biomet 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. NeoGenesis Co. Ltd 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Glofinn oy Overview 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 T Biotechnology (T Lab), 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Regen Lab SA 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. SDD Medical Group Ltd Overview 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. IntraVita International Limited Overview 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Exactech Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Arthrex Inc 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.16. Biotechnology Institute (bti 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Europe Platelet Rich Plasma Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Europe Platelet Rich Plasma Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Europe Platelet Rich Plasma Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Europe Platelet Rich Plasma Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.2. Kits 7.2.1. Kit By Type 7.2.1.1. Pure Platelet-Rich Plasma (P-PRP) 7.2.1.2. Leukocyte-Rich Platelet-Rich Plasma (L-PRP) 7.2.1.3. Leukocyte-Platelet-Rich Fibrin (L-PRF) 7.2.1.4. Pure Platelet-Rich Fibrin (P-PRF) 7.2.2. Kit By Origin 7.2.2.1. Autologous Platelet-Rich Plasma 7.2.2.2. Homologus Platelet-Rich Plasma 7.2.2.3. Allogeneic Platelet-Rich Plasma
8. Europe Platelet Rich Plasma Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Cosmetic/Aesthetic/Hair Fall Treatment 8.2. Orthopedics/Rehabilitation medicine 8.3. Dentistry 8.4. Ophthalmology 8.5. Research and Development 8.6. Veterinary
9. Europe Platelet Rich Plasma Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Physician's office/Private Practice/Veterinary Clinics 9.2. Hospitals 9.3. Orthopedic Clinics 9.4. Cosmetic/dermatology/Trichology Clinics 9.5. Academic & Research Institutes
10. North America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Europe Platelet Rich Plasma Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Terumo BCT 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Zimmer Biomet 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. NeoGenesis Co. Ltd 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Glofinn oy Overview 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 T Biotechnology (T Lab), 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Regen Lab SA 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. SDD Medical Group Ltd Overview 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. IntraVita International Limited Overview 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Exactech Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Arthrex Inc 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.16. Biotechnology Institute (bti 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics